Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet6 clinical inputsPatient data not stored

Community ASCVD Screening Yield Calculator (NNS & NNT)

Community ASCVD Screening Yield Calculator: Explanation and Clinical Context This tool estimates the yield and population-level impact of community cardiovascular risk screening followed by statin therapy for primary prevention. Inputs include: average 10-year ASCVD risk among screen-positive individuals, expected LDL-C reduction (mmol/L) with the chosen regimen, treatment uptake, adherence, screen-positivity, and sc

Interactive worksheet

Clinical inputs

0/6 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

Community ASCVD Screening Yield Calculator: Explanation and Clinical Context This tool estimates the yield and population-level impact of community cardiovascular risk screening followed by statin therapy for primary prevention. Inputs include: average 10-year ASCVD risk among screen-positive individuals, expected LDL-C reduction (mmol/L) with the chosen regimen, treatment uptake, adherence, screen-positivity, and screening coverage. The model converts LDL-C lowering into a proportional relative risk reduction (RRR) using the Cholesterol Treatment Trialists’ (CTT) framework: each 1 mmol/L LDL-C reduction ≈ 22% reduction in major vascular events, operationalized as RRR = 1 − 0.78LDLdrop.

The absolute risk reduction (ARR) for an individual = baseline 10-year risk × RRR. NNT = 1 / ARR (over 10 years). The community-level NNS is scaled by screening positivity × effective treatment fraction (uptake × adherence) and coverage.

Outputs include per-screened and per-invited NNS, as well as events prevented per 1000 screened.

Evidence & references2 primary sources mapped
  1. Source 1

    • CTT Collaboration. Lancet 2010; 376:1670–1681; 2012; 380:581–590. • Silverman MG et al. JAMA 2016; 316:1289–1297. • Mortensen MB et al. JAMA Cardiol

  2. Source 2

    • USPSTF. Statins for Primary Prevention. Evidence Review 2022.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

Smoking Cessation Cardiac Event Reduction Model (Policy Impact)

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

Salt Reduction Population Risk Reduction Estimator

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

National Sudden Cardiac Death (SCD) Registry Utility Estimator

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

Mobile Clinic Detection Probability Index (Rural CAD Screening) Calculator

Population Screening, Public Health & Cost-Effectiveness Tools
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.